Opinion

Video

Acute Lymphoblastic Leukemia: Trial Data From the ASCO and EHA 2023 Annual Meetings

Author(s):

Elias Jabbour, MDJames M. Foran, MD

Shared insight from key opinion leaders on clinical trial data in acute lymphoblastic leukemia from the ASCO 2023 and EHA 2023 Annual Meetings.

Related Videos
Timothy Hughes, MD, MBBS, FRACP, FRCPA
Ben Levy, MD, and Yan Leyfman, MD
BTK Inhibitors in CLL : Second Generation Drugs and Beyond
Carrie L. Kitko, MD
Lori A. Leslie, MD
Lori A. Leslie, MD
Changchun Deng, MD, PhD
Guenther Koehne, MD, PhD
Ibrahim Aldoss, MD
Andrew P. Jallouk, BS, MD, PhD, assistant professor, Vanderbilt University
Related Content
Eunice S. Wang, MD
June 6th 2024

Wang Expands on the Continued Investigation of Targeted Therapies in Relapsed/Refractory AML

OncLive On Air
March 18th 2024

Revisit the OncLive On Air Episodes From February 2024

Daniel DeAngelo MD, PhD
June 4th 2024

OS Data Could Dictate Next Directions for Uproleselan in R/R AML

Matthew Lunning, DO, FACP
November 30th 2023

Lunning and Jacobson Dissect the Role of CAR T-Cell Therapy in Follicular Lymphoma

DLBCL
June 2nd 2024

Tucidinostat Plus R-CHOP Improves EFS in DLBCL Expressing MYC and BCL2

Peter Borchmann, MD, of University Hospital of Cologne
June 1st 2024

BrECADD Regimen Improves PFS vs eBEACOPP Regimen in Advanced Classical Hodgkin Lymphoma